IP Verse

Am competitive analysis

Latest oppositions filed by Am

Explore patent oppositions filed by Am against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 23, 2026
Patent NumberTitleApplicantOpposition Date
EP2882444
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMAJun 17, 2026
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 17, 2026
EP3813549
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 16, 2026
EP3603648
Complex Of Nucleic Acid Medicine And Multibranched LipidSHIONOGIJun 15, 2026
EP2965752
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIESJun 3, 2026
EP4380893
Method For Hydrogen Production Coupled With Co2 CaptureKT TECHJun 3, 2026
EP4403081
Cleaner HolderLG ELECTRONICSJun 3, 2026
EP4185318
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026
EP4385509
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026
EP4074331
Compositions And Methods For Internalizing EnzymesREGENERON PHARMACEUTICALSMay 27, 2026

Latest patents of Am opposed by its competitors

Explore Am's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 23, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3630114
May 20, 2026Methods Of Treating Fabry Patients Having Renal Impairment1
EP2382228
Jan 7, 2026Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases4
EP3028842
Oct 8, 2025Powder Compositions Made Of Thermoplastics And Use Of The Compositions5
EP3381942
Oct 1, 2025A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor2
EP3658203
Oct 1, 2025Drug Delivery Device With Gear Module And Related Method Of Assembly2
EP3958838
Sep 10, 2025Method For Preparing Stable Peptide Formulations1
EP4037735
Sep 3, 2025Drug Delivery Device2
EP4385509
Sep 3, 2025Migalastat Formulations Having Improved Pharmacokinetics4
EP4340842
Aug 27, 2025Sotorasib Dosing Regimen1
EP3756650
Aug 20, 2025Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione11

Latest PTAB cases involving Am

Discover the latest PTAB cases involving Am, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 22, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Am

PGR2026-00062Jun 25, 2026AMERICA UGREENPending
PGR2026-00053Jun 1, 2026AMBILIGHTLANNRAY OPTOELECTRONICS ZHENJIANGPending
IPR2026-00260May 26, 2026AMNEAL PHARMACEUTICALSGENENTECHPending
IPR2026-00361May 26, 2026AMAZONCOM SERVICESPending
IPR2026-00367May 18, 2026AMBILIGHTLANNRAY OPTOELECTRONICS ZHENJIANGPending
IPR2026-00280Mar 23, 2026AMAZONCOM SERVICESSMART SPEAKERPending
IPR2026-00276Feb 28, 2026AMAZONCOM SERVICESSMART SPEAKERTrial Instituted
IPR2026-00193Jan 9, 2026AMAZONCOMINTERDIGITAL VCTrial Instituted
IPR2026-00195Jan 9, 2026AMAZONCOMINTERDIGITAL MADISONTrial Instituted
IPR2026-00192Jan 5, 2026AMAZONCOM SERVICESINTERDIGITAL VCInstitution Denied

Peer Comparison New

IP litigation analysis comparing Am with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 23, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMGEN9145811
MAIWALD151 - - -
REGENERON PHARMACEUTICALS38120932
STRAWMAN376 - - -